COGT
$29.52+0.03%
Cogent Biosciences Inc.Stock · HealthcareRussell 2000 0.2%Nasdaq Composite 0.01%Russell 3000 0.009%US Stock Market 0.009%
COGT financial statements
The full income statement, balance sheet, and cash-flow statement for Cogent Biosciences Inc. (COGT), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 109.5M2024-09 110.5M2024-12 113.9M2025-03 113.9M2025-06 139.7M2025-09 142.4M2025-12 162.3M2026-03 170.9M2026-06 173.5M+58.5% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Research & development | 270M+16.0% | 233M+33.9% | 174M+42.9% | 122M+117.5% | 55.9M+117.2% | |
| Selling, general & administrative | 63.6M+46.9% | 43.3M+25.9% | 34.4M+31.1% | 26.2M+33.5% | 19.6M+12.7% | |
| General & administrative | 63.6M+46.9% | 43.3M+25.9% | 34.4M+31.1% | 26.2M+33.5% | 19.6M+12.7% | |
| Operating income | -333M-20.8% | -276M-32.6% | -208M-40.8% | -148M-95.7% | -75.6M+8.1% | |
| Interest expense | 3.06M | — | — | — | — | |
| Interest & investment income | 14.7M-18.8% | 18.1M+38.3% | 13.1M+227.8% | 3.99M+754.2% | 467K+224.3% | |
| Other non-operating income | -20.0K-101.0% | 1.99M+111.2% | 943K-58.1% | 2.25M-31.4% | 3.28M-55.6% | |
| Income tax | 0.00 | — | — | — | — | |
| -329M-28.6% | -256M-33.0% | -192M-37.2% | -140M-94.0% | -72.3M+3.4% | ||
| Net income to common | — | — | -192M-37.2% | -140M-94.0% | -72.3M+59.7% | |
| -$2.16-11.3% | -$1.94+0.0% | -$1.94-12.1% | -$1.73+7.5% | -$1.87 | ||
| EPS (basic) | -$2.16-11.3% | -$1.94+0.0% | -$1.94-12.1% | -$1.73+7.5% | -$1.87 | |
| Weighted-avg shares (basic) | 129M+24.1% | 104M+30.4% | 79.7M+35.6% | 58.7M+51.7% | 38.7M | |
| Weighted-avg shares (diluted) | 129M+24.1% | 104M+30.4% | 79.7M+35.6% | 58.7M+51.7% | 38.7M | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 910M+207.1% | 296M+9.5% | 271M+2.2% | 265M+19.0% | 223M-9.1% | ||
| Cash & equivalents | 312M+217.8% | 98.2M+84.4% | 53.2M-61.9% | 140M-36.3% | 220M-9.3% | |
| Prepaid expenses | 9.59M+2.1% | 9.39M+85.6% | 5.06M+14.1% | 4.43M+50.4% | 2.95M+8.3% | |
| 938M+185.9% | 328M+4.6% | 313M+4.2% | 301M+29.6% | 232M-7.5% | ||
| Property, plant & equipment | 5.46M-15.6% | 6.47M-22.5% | 8.34M+7.2% | 7.78M+356.2% | 1.71M+1173.1% | |
| Operating lease right-of-use | 18.1M-10.0% | 20.1M-8.6% | 22.0M-5.7% | 23.3M+741.4% | 2.77M-40.0% | |
| Other non-current assets | 3.30M-32.1% | 4.86M-0.0% | 4.86M+2.5% | 4.75M+27.3% | 3.73M | |
| 64.0M+14.8% | 55.7M+46.0% | 38.2M+42.2% | 26.8M+57.2% | 17.1M+30.4% | ||
| Accounts payable | 9.50M-20.9% | 12.0M+12.7% | 10.7M+82.4% | 5.84M+67.7% | 3.48M+375.8% | |
| Current lease liability | 1.55M-1.2% | 1.56M+12.9% | 1.39M-2.6% | 1.42M-38.8% | 2.32M+13.3% | |
| 301M+320.7% | 71.6M+28.7% | 55.6M+23.4% | 45.1M+151.7% | 17.9M+10.2% | ||
| Long-term debt | 223M | 0.00 | — | — | — | |
| Non-current lease liability | 14.4M-9.7% | 15.9M-9.0% | 17.5M-4.2% | 18.2M+2093.3% | 831K-73.7% | |
| Operating lease liability (total) | 15.9M-9.0% | 17.5M-7.4% | 18.9M-4.1% | 19.6M+522.8% | 3.15M-39.4% | |
| Other non-current liabilities | 33.0K | 0.00 | — | — | — | |
| 636M+148.3% | 256M-0.6% | 258M+0.8% | 256M+19.4% | 214M-8.7% | ||
| Common stock | 161K+46.4% | 110K+27.9% | 86.0K+22.9% | 70.0K+59.1% | 44.0K+37.5% | |
| Additional paid-in capital | 1.73B+72.7% | 1.00B+25.4% | 801M+33.3% | 601M+50.4% | 400M+24.0% | |
| Retained earnings | -1.19B-38.3% | -859M-42.4% | -604M-46.8% | -411M-51.8% | -271M-36.4% | |
| Accumulated other comprehensive income | 355K-20.6% | 447K+81.7% | 246K+336.5% | -104K | — | |
| Total liabilities & equity | 938M+185.9% | 328M+4.6% | 313M+4.2% | 301M+29.6% | 232M-7.5% | |
| Common shares issued | 161M+45.7% | 110M+28.3% | 86.1M+23.2% | 69.9M+59.6% | 43.8M+35.4% | |
| Common shares outstanding | 161M+45.7% | 110M+28.3% | 86.1M+23.2% | 69.9M+59.6% | 43.8M+35.4% | |
| Shares outstanding (cover) | 162M+42.6% | 114M+9.6% | 104M+48.6% | 69.9M+52.7% | 45.8M+23.2% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -264M-27.3% | -208M-35.3% | -154M-29.5% | -119M-101.9% | -58.8M-63.9% | ||
| Depreciation & amortization | 2.60M+4.0% | 2.50M+8.7% | 2.30M+187.5% | 800K+444.2% | 147K-79.6% | |
| Share-based compensation | 46.1M+16.0% | 39.7M+29.8% | 30.6M+66.7% | 18.4M+57.2% | 11.7M+94.2% | |
| Deferred income taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Change in payables | -2.51M-284.8% | 1.36M-71.8% | 4.81M+104.0% | 2.36M-14.2% | 2.75M+212.2% | |
| -400M-1143.8% | 38.3M+139.1% | -97.8M+21.6% | -125M-7155.3% | -1.72M-120.4% | ||
| Capital expenditure | 1.55M+171.2% | 573K-79.5% | 2.80M-59.3% | 6.86M+299.2% | 1.72M | |
| Free cash flow | -266M-27.7% | -208M-33.2% | -156M-24.6% | -126M-107.5% | -60.5M | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 878M+309.5% | 214M+31.1% | 164M-0.0% | 164M+330.7% | 38.0M-83.6% | ||
| Long-term debt issued | 49.3M | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00-100.0% | 162M | 0.00 | 0.00-100.0% | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | 214M+376.8% | 44.9M+151.1% | -87.9M-10.2% | -79.8M-254.6% | -22.5M-111.0% | |
| Interest paid | 2.02M | 0.00 | 0.00 | — | — | |
| Income taxes paid | 0.00 | — | — | — | — | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 5.77B+549.2% | 888M+75.4% | 506M-37.3% | 808M+105.5% | 393M-5.9% | |
| P/S | 732.5×+549.2% | 112.8×+75.4% | 64.3×-37.3% | 102.7×+105.5% | 49.9×-5.9% | |
| P/B | 9.1×+161.5% | 3.5×+107.3% | 1.7×-40.0% | 2.8×+51.8% | 1.8×+3.1% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: COGT’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all COGT filings on SEC EDGAR → Not investment advice.